ESTERN Medical CRO: LEADING IN DIAGNOSTIC RADIOLOGICAL IMAGING CONTRIBUTION TO TRANSLATIONAL MEDICINE
In the last decade, a transformative shift has occurred in medical disciplines, giving rise to translational medicine—an effort to bridge preclinical and clinical trial phases for similar biological targets. ESTERN Medical CRO has been at the forefront of this movement, particularly in the realm of diagnostic radiological imaging, contributing significantly to the advancement of translational medicine.
Evolution of Translational Medicine
Translational medicine aims to connect preclinical and clinical phases, focusing on similar biological targets. This paradigm shift has been particularly impactful in molecular imaging, a field that visualizes fundamental life processes. Molecular imaging, enabled by advances in molecular biology, allows the identification of cellular mechanisms within a living organism.
Major Trends in Molecular Imaging
Functional imaging, a cornerstone of molecular imaging, is experiencing significant expansion, particularly in anti-tumor products like antiangiogenic or antivascular molecules. This approach contributes to a deeper understanding and diagnosis of pathological processes, paving the way for new treatments and effective patient monitoring.
Anticipated trends in the medium term include personalized medicine, relying on validated biomarkers, and “Theranostics,” combining targeted therapeutic agents with diagnostic applications, supporting the monitoring of treatment efficacy.
Cardiovascular Diseases: Key Facts and Trial Challenges
Cardiovascular illness is a leading global cause of mortality, necessitating solutions to prevent the risk of cardiovascular accidents. A significant challenge lies in developing a clinical trial product capable of discriminating at-risk from stable plaques, a crucial factor in preventing CVAs.
Cancer: Key Facts and Trial Challenges
Cancer stands as the second leading cause of death in the European Union, requiring adaptive treatments and reliable recurrence identification. ESTERN Medical CRO Life Sciences aims to develop specific products for detecting ovarian cancer recurrence and monitoring treatments, emphasizing the importance of targeted diagnostic applications.
Inflammatory and Neurodegenerative Diseases: Key Facts and Trial Challenges
Alzheimer’s disease affects over 14 million people in the USA and Europe, with an estimated healthcare cost of $100 billion annually. The challenge is to contribute to early and reliable Alzheimer’s disease diagnosis and improve treatment responses by developing contrast agents and specific products for lesion visualization.
Commitment to Advancing MRI Applications
ESTERN Medical CRO is committed to pushing the boundaries of MRI applications, evolving from anatomical to molecular imaging. The focus is on increasing sensitivity in contrast and spatial resolution, addressing challenges posed by increased magnetic fields, and adopting an integrated vision of technology product-machine concepts.
Conclusion: A Decade of Contributions to Clinical Trials
Since the early 2000s, ESTERN Medical CRO Life Sciences has played a pivotal role in advancing clinical trials in diagnostic radiological imaging, enhancing patient care globally. The commitment to innovation, scientific expertise, and collaboration with sponsors positions ESTERN Medical as a leader in addressing 21st-century healthcare challenges.
Our Broad Radiological Trial Experience and CRO Advantage
ESTERN Medical CRO’s extensive experience in managing radiological imaging studies across multiple modalities positions it as a leader in the field. With a heritage specializing in imaging, the team successfully handles imaging compounds for global sponsors in the US & Latin America.
The management team, composed of respected professionals, ensures efficient study conduct through rapid study start-up, excellent relationships with local regulators, and access to qualified sites. With a strong senior project management approach, ESTERN Medical CRO guarantees studies run efficiently, maintaining consistency across sites, and delivering quality results on time and within budget.
Choose ESTERN Medical CRO for unparalleled expertise in diagnostic radiological imaging and a commitment to advancing translational medicine through innovative clinical trial solutions.
